| - GRCh37:
- Chr22:36691759
- GRCh38:
- Chr22:36295713
| MYH9 | E1093K | Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(May 21, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36697022
- GRCh38:
- Chr22:36300976
| LOC126863137, MYH9 | R905C | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
| Conflicting interpretations of pathogenicity
(Jun 22, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36692980
- GRCh38:
- Chr22:36296934
| MYH9 | S1061C | not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
| Uncertain significance
(May 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36684790
- GRCh38:
- Chr22:36288744
| MYH9 | K1585Q | not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
| Conflicting interpretations of pathogenicity
(Oct 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36681727
- GRCh38:
- Chr22:36285681
| MYH9 | R1751W | not specified, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
| Uncertain significance
(May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36690302
- GRCh38:
- Chr22:36294256
| MYH9 | E1225K | not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
| Uncertain significance
(Mar 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36723520
- GRCh38:
- Chr22:36327475
| MYH9 | | not specified, not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss,
Autosomal dominant nonsyndromic hearing loss 17 | Likely benign
(Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36692870
- GRCh38:
- Chr22:36296824
| MYH9 | | not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
| Likely benign
(Mar 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36684996
- GRCh38:
- Chr22:36288950
| MYH9 | | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
| Likely benign
(Sep 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36716829
- GRCh38:
- Chr22:36320784
| MYH9 | | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
| Likely benign
(Nov 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36681149
- GRCh38:
- Chr22:36285103
| MYH9 | | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
| Likely benign
(Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36710226
- GRCh38:
- Chr22:36314181
| MYH9 | | Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
| Likely benign
(Oct 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36696305
- GRCh38:
- Chr22:36300259
| LOC126863137, MYH9 | | not provided, Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
| Likely benign
(Mar 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36688248
- GRCh38:
- Chr22:36292202
| MYH9 | | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
| Likely benign
(Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36689355
- GRCh38:
- Chr22:36293309
| MYH9 | | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
| Benign/Likely benign
(Oct 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36696887
- GRCh38:
- Chr22:36300841
| LOC126863137, MYH9 | | Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
| Likely benign
(Apr 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36716245
- GRCh38:
- Chr22:36320200
| MYH9 | | Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
| Benign/Likely benign
(Mar 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36684333
- GRCh38:
- Chr22:36288287
| MYH9 | R1633W | not provided, Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
| Uncertain significance
(Jun 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36695043
- GRCh38:
- Chr22:36298997
| MYH9 | L1008V | Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
| Conflicting interpretations of pathogenicity
(Nov 15, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36684859
- GRCh38:
- Chr22:36288813
| MYH9 | L1562V | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
| Conflicting interpretations of pathogenicity
(Jun 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36700168
- GRCh38:
- Chr22:36304122
| MYH9 | R755C | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
| Conflicting interpretations of pathogenicity
(Mar 10, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36691584
- GRCh38:
- Chr22:36295538
| MYH9 | T1151M | Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
| Conflicting interpretations of pathogenicity
(Feb 21, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36714278
- GRCh38:
- Chr22:36318233
| MYH9 | V401I | Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
| Conflicting interpretations of pathogenicity
(Jun 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36681805
- GRCh38:
- Chr22:36285759
| MYH9 | R1725W | not provided, Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
| Uncertain significance
(Jan 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36690298
- GRCh38:
- Chr22:36294252
| MYH9 | R1226L | not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
| Uncertain significance
(May 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36681336
- GRCh38:
- Chr22:36285290
| MYH9 | H1772Y | not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
| Uncertain significance
(Mar 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36689870
- GRCh38:
- Chr22:36293824
| MYH9 | D1293N | not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
| Uncertain significance
(Dec 28, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36684347
- GRCh38:
- Chr22:36288301
| MYH9 | S1628L | Inborn genetic diseases, Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss,
not provided | Conflicting interpretations of pathogenicity
(Aug 16, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36692968
- GRCh38:
- Chr22:36296922
| MYH9 | A1065T | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
| Uncertain significance
(Mar 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36690247
- GRCh38:
- Chr22:36294201
| MYH9 | S1243L | Autosomal dominant nonsyndromic hearing loss 17, Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
| Uncertain significance
(Mar 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36700135
- GRCh38:
- Chr22:36304089
| MYH9 | G766S | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
| Uncertain significance
(Mar 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36685336
- GRCh38:
- Chr22:36289290
| MYH9 | A1451V | not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
| Uncertain significance
(Jul 6, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36745004
- GRCh38:
- Chr22:36348959
| MYH9 | N93S | not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
| Uncertain significance
(Oct 4, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36696236
- GRCh38:
- Chr22:36300190
| LOC126863137, MYH9 | | Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
| Benign
(Oct 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36702020
- GRCh38:
- Chr22:36305974
| MYH9 | | Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
| Likely benign
(Apr 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36714312
- GRCh38:
- Chr22:36318267
| MYH9 | | not provided, Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
| Benign/Likely benign
(Jul 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36690298
- GRCh38:
- Chr22:36294252
| MYH9 | R1226P | not provided, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jun 29, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36696878
- GRCh38:
- Chr22:36300832
| MYH9, LOC126863137 | | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
| Benign/Likely benign
(Aug 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36689391
- GRCh38:
- Chr22:36293345
| MYH9 | A1360G | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
| Uncertain significance
(Nov 2, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36691533
- GRCh38:
- Chr22:36295487
| MYH9 | | not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
| Benign/Likely benign
(Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36690158
- GRCh38:
- Chr22:36294112
| MYH9 | D1273N | not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
| Conflicting interpretations of pathogenicity
(Jul 26, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36680315
- GRCh38:
- Chr22:36284269
| MYH9 | | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
| Likely benign
(Apr 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36681801
- GRCh38:
- Chr22:36285755
| MYH9 | R1726H | not specified, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
| Uncertain significance
(Aug 3, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36690274
- GRCh38:
- Chr22:36294228
| MYH9 | K1234R | Inborn genetic diseases, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17,
not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss | Uncertain significance
(Oct 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36718520
- GRCh38:
- Chr22:36322475
| MYH9 | A220V | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not specified
| Uncertain significance
(Apr 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36695098
- GRCh38:
- Chr22:36299052
| MYH9 | | Autosomal dominant nonsyndromic hearing loss 17, MYH9-related disorder | Conflicting interpretations of pathogenicity
(Jan 13, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36688093
- GRCh38:
- Chr22:36292047
| MYH9 | D1428G | Autosomal dominant nonsyndromic hearing loss 17, MYH9-related disorder | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36684815
- GRCh38:
- Chr22:36288769
| MYH9 | | Autosomal dominant nonsyndromic hearing loss 17, MYH9-related disorder | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36684413
- GRCh38:
- Chr22:36288367
| MYH9 | S1606L | Autosomal dominant nonsyndromic hearing loss 17, MYH9-related disorder, Proteinuria,
not specified | Conflicting interpretations of pathogenicity
(Mar 3, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36681953
- GRCh38:
- Chr22:36285907
| MYH9 | R1703Q | Autosomal dominant nonsyndromic hearing loss 17, Inborn genetic diseases, not provided,
MYH9-related disorder | Conflicting interpretations of pathogenicity
(Sep 2, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36678828
- GRCh38:
- Chr22:36282782
| MYH9 | | Autosomal dominant nonsyndromic hearing loss 17, MYH9-related disorder | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36678810
- GRCh38:
- Chr22:36282764
| MYH9 | | MYH9-related disorder, not provided, Autosomal dominant nonsyndromic hearing loss 17,
not specified | Conflicting interpretations of pathogenicity
(Jul 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36678519
- GRCh38:
- Chr22:36282473
| MYH9 | | Autosomal dominant nonsyndromic hearing loss 17, MYH9-related disorder | Conflicting interpretations of pathogenicity
(May 3, 2017) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36745167
- GRCh38:
- Chr22:36349122
| MYH9 | S39G | Autosomal dominant nonsyndromic hearing loss 17, MYH9-related disorder | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36715645
- GRCh38:
- Chr22:36319600
| MYH9 | G350S | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36715610
- GRCh38:
- Chr22:36319565
| MYH9 | D361E | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36708282
- GRCh38:
- Chr22:36312237
| MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36708267
- GRCh38:
- Chr22:36312222
| MYH9 | A519T | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36708232
- GRCh38:
- Chr22:36312187
| MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36701091
- GRCh38:
- Chr22:36305045
| MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Benign/Likely benign
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36684375
- GRCh38:
- Chr22:36288329
| MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Feb 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36681787
- GRCh38:
- Chr22:36285741
| MYH9 | I1731V | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36681272
- GRCh38:
- Chr22:36285226
| MYH9 | K1793R | MYH9-related disorder, not provided, Autosomal dominant nonsyndromic hearing loss 17
| Conflicting interpretations of pathogenicity
(May 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36678719
- GRCh38:
- Chr22:36282673
| MYH9 | E1960K | MYH9-related disorder, not provided, Autosomal dominant nonsyndromic hearing loss 17
| Conflicting interpretations of pathogenicity
(Jan 10, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36678466
- GRCh38:
- Chr22:36282420
| MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36678441
- GRCh38:
- Chr22:36282395
| MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36744935
- GRCh38:
- Chr22:36348890
| MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17, not provided
| Conflicting interpretations of pathogenicity
(Aug 19, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36737460
- GRCh38:
- Chr22:36341415
| MYH9 | H149N | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36737457
- GRCh38:
- Chr22:36341412
| MYH9 | I150V | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36698671
- GRCh38:
- Chr22:36302625
| MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Conflicting interpretations of pathogenicity
(Jan 13, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36690236
- GRCh38:
- Chr22:36294190
| MYH9 | R1247C | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Conflicting interpretations of pathogenicity
(Jan 12, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36712669
- GRCh38:
- Chr22:36316624
| MYH9 | M425L | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36705446
- GRCh38:
- Chr22:36309401
| MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17, not provided
| Conflicting interpretations of pathogenicity
(Oct 11, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36697720
- GRCh38:
- Chr22:36301674
| MYH9 | | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, MYH9-related disorder,
Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Dec 27, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36689895
- GRCh38:
- Chr22:36293849
| MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17, not provided
| Conflicting interpretations of pathogenicity
(Mar 21, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36685222
- GRCh38:
- Chr22:36289176
| MYH9 | M1489T | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36684328
- GRCh38:
- Chr22:36288282
| MYH9 | | MYH9-related disorder, not provided, Autosomal dominant nonsyndromic hearing loss 17
| Conflicting interpretations of pathogenicity
(Jul 28, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36680552
- GRCh38:
- Chr22:36284506
| MYH9 | R1830H | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36678701
- GRCh38:
- Chr22:36282655
| MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Conflicting interpretations of pathogenicity
(Jan 12, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36678641
- GRCh38:
- Chr22:36282595
| MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36678389
- GRCh38:
- Chr22:36282343
| MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Benign/Likely benign
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36783918
- GRCh38:
- Chr22:36387873
| MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36722673
- GRCh38:
- Chr22:36326628
| MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36702101
- GRCh38:
- Chr22:36306055
| MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36697604
- GRCh38:
- Chr22:36301558
| MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Conflicting interpretations of pathogenicity
(Jan 12, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36697082
- GRCh38:
- Chr22:36301036
| LOC126863137, MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36691583
- GRCh38:
- Chr22:36295537
| MYH9 | | MYH9-related disorder, not provided, Autosomal dominant nonsyndromic hearing loss 17
| Conflicting interpretations of pathogenicity
(May 25, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36689393
- GRCh38:
- Chr22:36293347
| MYH9 | | MYH9-related disorder, not provided, Autosomal dominant nonsyndromic hearing loss 17
| Conflicting interpretations of pathogenicity
(Aug 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36682866
- GRCh38:
- Chr22:36286820
| MYH9 | E1653D | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36678075
- GRCh38:
- Chr22:36282029
| MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36677384
- GRCh38:
- Chr22:36281338
| MYH9 | | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:36680233
- GRCh38:
- Chr22:36284187
| MYH9 | A1891T | MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss,
not provided | Uncertain significance
(Aug 30, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36689462
- GRCh38:
- Chr22:36293416
| MYH9 | | not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
| Benign/Likely benign
(Oct 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36705382
- GRCh38:
- Chr22:36309337
| MYH9 | | Kidney disorder, Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss,
not provided | Conflicting interpretations of pathogenicity
(Apr 9, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36700210
- GRCh38:
- Chr22:36304164
| MYH9 | | Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
| Likely benign
(May 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36708087
- GRCh38:
- Chr22:36312042
| MYH9 | | Autosomal dominant nonsyndromic hearing loss 17, MYH9-related disorder, not provided
| Conflicting interpretations of pathogenicity
(Apr 12, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:36680140
- GRCh38:
- Chr22:36284094
| MYH9 | | not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
| Likely benign
(Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36688158
- GRCh38:
- Chr22:36292112
| MYH9 | | not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
| Likely benign
(Oct 12, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36702050
- GRCh38:
- Chr22:36306004
| MYH9 | | not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
| Likely benign
(Aug 11, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:36680499
- GRCh38:
- Chr22:36284453
| MYH9 | L1848V | not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
| Conflicting interpretations of pathogenicity
(Dec 5, 2022) | criteria provided, conflicting interpretations |